<DOC>
	<DOCNO>NCT00631943</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety Lyrica Indian patient nerve pain</brief_summary>
	<brief_title>A Study Evaluate Efficacy Safety Pregabalin ( Lyrica ) Treatment Nerve Pain</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Inclusion criterion : Peripheral neuropathic pain Score least 40 mm VAS SFMPQ screen baseline Completion least 4 daily pain diary entry average daily pain score least 4 7 day prior baseline Exclusion criterion : ( none )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>